https://www.selleckchem.com/Bcl-2.html
Conclusions NASH will contribute to a significant clinical and economic burden in Hong Kong over the next two decades. Due to the limited number of donors and small number of liver transplants performed annually, patients with advanced liver disease due to NASH in Hong Kong are more likely to die from NASH than their counterparts in the western hemisphere. Thus rising prevalence of metabolic syndrome in elderly adults in Hong Kong make NASH an important consideration for clinicians and policy makers.A snapshot of how scientists are personally affe
Curtir
Comentario
Compartilhar
